We are live on
!
Find out more
CC
Colrain Capital Portfolio holdings
AUM
$259M
1-Year Est. Return
63.6%
This Fund
S&P 500
This Quarter
Est. Return
+20.84%
1 Year Est. Return
+63.6%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$49.2M
AUM Growth
+$7.76M
(+19%)
Cap. Flow
-$387K
Cap. Flow
% of AUM
-0.79%
Top 10 Holdings %
Top 10 Hldgs %
69.17%
Holding
31
New
2
Increased
–
Reduced
5
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
United Airlines
UAL
|
+$132K |
| 2 |
VanEck Oil Services ETF
OIH
|
+$127K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$358K |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$92.8K |
| 3 |
Delta Air Lines
DAL
|
+$72.7K |
| 4 |
The Mosaic Company
MOS
|
+$60.4K |
| 5 |
SLB Ltd
SLB
|
+$31K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.54% |
| 2 | Technology | 20.38% |
| 3 | Communication Services | 12.58% |
| 4 | Materials | 11.2% |
| 5 | Energy | 6.9% |
Similar funds
NAM
CCAM
QP
PW
BFP
TC
FC
GWM
Colrain Capital's Q4 2020 Portfolio in Review
As of Q4 2020, Colrain Capital held 31 positions worth $49.2M, up 19% from $41.5M the previous quarter. Its ten largest holdings account for 69% of the portfolio.
Colrain Capital's Q4 2020 filing shows 2 new, 5 reduced and 1 closed positions. Its largest new stake was United Airlines: 3,260 shares worth $141K. The largest sale was CVS Health, an estimated $358K.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 24% a quarter earlier, followed by Technology and Communication Services.
- Colrain Capital's largest Q4 2020 buy was United Airlines: 3,260 shares worth $141K.
- Colrain Capital's biggest Q4 2020 reduction was CVS Health, cutting an estimated $358K.
- Colrain Capital fully exited SLB Ltd in Q4 2020, selling an estimated $31K.
- Colrain Capital's ten largest holdings make up 69% of its $49.2M portfolio in Q4 2020.
- Colrain Capital opened 2 new positions and closed 1 in Q4 2020.
- Colrain Capital's portfolio value rose 19% quarter-over-quarter to $49.2M.
Based on Colrain Capital's 13F filing for Q4 2020, filed 2 Feb 2021.